FDA Grants Universal Clearance to Bezier Spinal Rod System
Dateline – FORT LAUDERDALE, Fla., Feb. 5, 2026 — Spinal Resources Inc. announced that the U.S. Food and Drug...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Dateline – FORT LAUDERDALE, Fla., Feb. 5, 2026 — Spinal Resources Inc. announced that the U.S. Food and Drug...
